IRIS
PALAZZO, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 310
EU - Europa 137
AS - Asia 92
AF - Africa 5
Totale 544
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 308
IT - Italia 64
SG - Singapore 58
NL - Olanda 38
CN - Cina 29
DE - Germania 10
IE - Irlanda 8
FI - Finlandia 6
CI - Costa d'Avorio 5
UA - Ucraina 5
IN - India 3
CA - Canada 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
FR - Francia 1
OM - Oman 1
SE - Svezia 1
TR - Turchia 1
Totale 544
Salva come PNG Salva come JPEG
Città #
Singapore 47
Amsterdam 38
Chandler 38
Santa Clara 33
Ashburn 21
Naples 18
Beijing 11
Napoli 11
Woodbridge 10
Falls Church 9
Rome 9
Nanjing 7
Wilmington 7
Jacksonville 6
Dearborn 5
Princeton 5
Kronberg 4
Millbury 4
Boardman 3
Boston 3
Council Bluffs 2
Des Moines 2
Kingston 2
Pozzuoli 2
Pune 2
Seattle 2
Torre del Greco 2
Arienzo 1
Avellino 1
Brindisi 1
Brno 1
Capua 1
Esslingen am Neckar 1
Giugliano In Campania 1
Guangzhou 1
Hebei 1
Jiaxing 1
Lappeenranta 1
Lawrence 1
Los Angeles 1
New York 1
Norwalk 1
Olomouc 1
Paris 1
Redwood City 1
Rimini 1
Scafati 1
Taizhou 1
Waltham Cross 1
Washington 1
Wuhan 1
Totale 327
Salva come PNG Salva come JPEG
Nome #
CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC 61
The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs 60
Role for non-proteolytic control of M-phase promoting factor activity at M-phase exit 59
ATM controls proper mitotic spindle structure 45
The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma 42
The end of mitosis from a phosphatase perspective 34
Requirement for proteolysis in spindle assembly checkpoint silencing. 28
(ADP-ribosyl)hydrolases: structure, function, and biology 26
PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders 19
ADP-ribosylation signalling and human disease 16
Serine is a new target residue for endogenous ADP-ribosylation on histones 16
Progress and outlook in studying the substrate specificities of PARPs and related enzymes 16
null 16
ADP-ribosylation: new facets of an ancient modification 16
Serine ADP-ribosylation in DNA-damage response regulation 14
ENPP1 processes protein ADP-ribosylation in vitro 14
The DarT/DarG Toxin–Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies 13
PARPs in genome stability and signal transduction: implications for cancer therapy 13
Serine is the major residue for ADP-ribosylation upon DNA damage 12
Processing of protein ADP-ribosylation by Nudix hydrolases 11
MacroD1 Is a Promiscuous ADP-Ribosyl Hydrolase Localized to Mitochondria 11
Disruption of macrodomain protein SCO6735 increases antibiotic production in Streptomyces coelicolor 11
Targeting ADP-ribosylation as an antimicrobial strategy 10
Studying catabolism of protein ADP-ribosylation 10
Serine ADP-ribosylation reversal by the hydrolase ARH3 9
Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease 9
Mono(ADP-ribosyl)ation Enzymes and NAD + Metabolism: A Focus on Diseases and Therapeutic Perspectives 1
Totale 592
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.616
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 0 2 5 10 0 0 2 3 1
2020/202115 0 1 1 1 2 1 1 0 3 1 1 3
2021/202259 0 0 0 3 5 4 2 0 16 1 19 9
2022/2023190 6 6 1 9 28 20 0 25 30 44 13 8
2023/2024133 11 30 15 10 3 14 5 15 0 5 17 8
2024/2025122 44 29 4 16 29 0 0 0 0 0 0 0
Totale 592